Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CXCR4 Stable Cell Line

    [CAT#: S01YF-0923-PY47]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX368 Magic™ Rat CXCR4 in Vitro Calcium Flux Assay Rat CHO-K1-Gα16 Calcium Flux Assay

    Product Information

    Target Protein
    CXCR4
    Target Family
    Chemokine Family
    Target Protein Species
    Human
    Host Cell Type
    MDA-MB-231;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Whim Syndrome 1;Macroglobulinemia
    Gene ID
    Human: 7852
    UniProt ID
    Human: P61073

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CXCR4, a chemokine receptor, has emerged as a pivotal player in various scientific research domains. It plays a significant role in tumor microcirculation, making it a valuable target for evaluating circulating biomarkers in thoracic surgeries and translational cancer research. Furthermore, CXCR4's involvement in cardiovascular development has been highlighted, especially in the signaling pathways during epicardial development, which offers potential therapeutic targets for heart repair. In the realm of oncology, the CXCR4 antagonist combined with other inhibitors has shown promising clinical responses in metastatic cancer patients, emphasizing its potential in enhancing antitumor immune activation. Moreover, the structures of CXCR4 bound to antagonists have been elucidated, revealing its potential role in regulating signaling. The receptor's role in cell proliferation and tissue regeneration has also been underscored, suggesting the need for a deeper understanding of its complex signaling for effective organ repair.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CXCR4 Stable Cell Line (S01YF-0923-PY47). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Paul (Verified Customer)

    What is the significance of CXCR4 in the context of human glioma? Nov 09 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CXCR4 silencing has been shown to suppress the invasive and adhesive potential of U87 glioma cells, providing a foundation for further research on the CXCR4 gene in human gliomas and potential targeted treatments. Nov 09 2021

    chat Kevin (Verified Customer)

    How does CXCR4 relate to acute myeloid leukemia (AML)? Jan 31 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Circular RNA PVT1 (circPVT1) is highly expressed in AML patients and is associated with shorter overall survival. CircPVT1 may exert oncogenic effects in THP-1 cells by stabilizing c-Myc protein expression and its downstream target, CXCR4. Jan 31 2022

    Published Data

    Fig.1 Inducing genetic suppression of CXCR4 expression within MDA-MB-231 breast cancer cells results in in vitro cellular proliferation.

    Cell proliferation in transduced MDA-MB-231 cells was assessed. Each clone initiated with 2x10^4 cells and incubated for 48 hours. Relative cell growth, determined in triplicate, was expressed as the ratio of mean absorbance for each clone after 48 hours to the mean absorbance of the initial 2x10^4 cells, as measured by the MTT assay. The results demonstrated a significant difference (P<0.01) compared to the pSuper-transduced control clone (7-2).

    Ref: Lapteva, Natalia, et al. "CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo." Cancer gene therapy 12.1 (2005): 84-89.

    Pubmed: 15472715

    DOI: 10.1038/sj.cgt.7700770

    Research Highlights

    Lyu F, et al. "Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated ." JCI insight, 2023.
    The study investigates the role of CXCR4, a key regulator of NK cell and dendritic cell development, in pregnancy. While its importance in early placental development and immune tolerance at the maternal-fetal interface is established, its specific function in pregnancy remains unclear. The research reveals that deletion of CXCR4 in adult mice, but not in the uterus, results in increased pregnancy loss and decreased litter size. These mice exhibited abnormal decidual NK cell aggregates and infiltration into trophoblast areas, as well as decreased expression of the NK cell granule effector granzyme B, indicating NK cell dysfunction. This was associated with placental vascular abnormalities and increased expression of inflammatory genes. Rescue of reproductive deficits was observed through transplanting wild type CXCR4+ bone marrow cells into CXCR4-deficient mice, which normalized NK cell function and placental vascular development. In conclusion, this study highlights the important role of maternal CXCR4 expression in immune cell function, placental development, and pregnancy maintenance.
    Pubmed: 37815869   DOI: 10.1172/jci.insight.172216

    Xu X, et al. "Sequence-directed concentration of G protein-coupled receptors in COPII vesicles.." iScience, 2023.
    The largest superfamily of plasma membrane signaling proteins, G protein-coupled receptors (GPCRs), remains largely unexplored in terms of their recruitment to COPII vesicles for forward delivery after synthesis in the endoplasmic reticulum (ER). In this study, it has been demonstrated that certain GPCRs, such as the Angiotensin II type 2 receptor (AT2R) and CXCR4, are highly concentrated at ER exit sites (ERES) before COPII budding. Furthermore, it has been found that specific di-acidic and 9-residue motifs are responsible for directing the concentration of these receptors, and also control their ER-Golgi traffic. It has also been observed that the AT2R interacts with the Sar1 GTPase, and that different GPCRs exhibit varying rates of ER-Golgi transport via COPII, independent of their concentration at ERES. These findings highlight the active capture of GPCRs by COPII through specific motifs and interactions with COPII components, which in turn, play a crucial role in their export dynamics and provide valuable insights into the targeting and forward trafficking of nascent GPCRs.
    Pubmed: 37810244   DOI: 10.1016/j.isci.2023.107969

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare